- Telehealth Visits
Allison Libby, PsyD
She | Her | HersPsychology (Child and Adolescent Psychology)- Telehealth Visits
Allison Libby, PsyD
She | Her | HersPsychology (Child and Adolescent Psychology)- Telehealth Visits
On this page
About me
Allison Libby is a psychologist who provides individual, family and group therapy for children and teens with anxiety and obsessive-compulsive spectrum disorders. She has a special interest in exposure-based therapies, which help people overcome certain fears through exposure to the source of the fear in a supervised environment. She also teaches UCSF residents and fellows how to utilize exposure therapy in their patient care.
Libby participates in research on the efficacy of clinical interventions and strategies for preventing provider burnout.
Libby earned her doctor of psychology degree from a program of the Pacific Graduate School of Psychology and Stanford University, the PGSP-Stanford PsyD Consortium.
Education
Fellowship
- Child Psychology, Kaiser Permanente - San Bruno
Internship
- Child Psychology, Childrens Hospital and Medical Center - Oakland
School
- PSYD, Palo Alto University - PGSP Stanford PsyD Consortium
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Psychology (Child and Adolescent Psychology)
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222326%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222326%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.